ATYR’s Market Quandary: Decoding the Ups and Downs of 2023

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase of 257.95%. However, over the past six months, we’ve seen a weaker performance of 35.80%. The price of ATYR fallen by 0.46% over the last 30 days. And in the last five days, it has surged by 5.36%.

Atyr Pharma Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $5.98 on 06/10/25, while the lowest price for the same duration was marked at $1.51 on 07/22/24.

52-week price history of ATYR Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Atyr Pharma Inc’s current trading price is -9.62% away from its 52-week high, while its distance from the 52-week low is 257.95%. The stock’s price range during this period has varied between$1.51 and $5.98. The Atyr Pharma Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.0 million for the day, a figure considerably lower than their average daily volume of 2.29 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Atyr Pharma Inc (ATYR) has experienced a quarterly rise of 89.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 481.07M and boasts a workforce of 59 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

ATYR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ATYR stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.16.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.